Pestalozzi advised Adragos Pharma on the deal, while Kellerhals Carrard advised the seller. Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to the investors and Kontivia Beteiligungen AG on this transaction. Baker McKenzie advised the sellers on all legal aspects of...
You must be a Standard 1 Year member to access this content.
CMS advised Bruker, while Kellerhals Carrard advised Biognosys AG. Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised BVF on the deal while Sheppard Mullin served as counsel to Laidlaw & Company (UK) Ltd. NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss...
You must be a Standard 1 Year member to access this content.
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as lead legal advisor to MoonLake Immunotherapeutics AG on this transaction. Walder Wyss has advised Merck KGaA on the deal. MoonLake Immunotherapeutics AG,...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard assisted Qnami on the deal. Quantum Tech startup Qnami closed its Series A Financing Round raising a total of CHF 4 million led by the...
You must be a Standard 1 Year member to access this content.
